Paving Your Road to Clean Label: From Formulation to Manufacturing and Marketing

Today’s consumers are more concerned about what is in their food and how it is made. As a culture for checking labels emerges, food supplement manufacturers are increasingly exploring opportunities for clean label products.
 
Introducing a clean label supplement – or reintroducing an existing supplement as clean label – requires manufacturers to reconsider all aspects of the product development process, including ingredient and excipient selection, dosage form choice, manufacturing, regulatory compliance and consumer communication.
 
This webinar will provide guidance on practical ways to implement a clean label strategy. A natural ingredient manufacturer will also highlight how to leverage specialty ingredients to give products a competitive advantage.
 
Speakers:

• Dominik Mattern, Business Development Manager, Capsugel
• Steve Peirce, President, Ribus, Inc. 

Register here

Innovations to Optimize Delivery of Probiotics

Consumers are driving changes in the health and nutrition and seek products that ensure success in their goals for a healthier lifestyle. With increased use of probiotics and consumer concerns about effective products for digestive health, product developers and brand managers are seeking ways to optimize delivery for probiotic and other acid-sensitive ingredients. 

Capsugel’s portfolio of dosage delivery systems leverages the latest science and engineering to help you capture your share of the market. Discover ways to increase your product’s effectiveness, consumer satisfaction and shelf stability.

Register here

Biologic Comparison of a Novel Inhaled Insulin DPI Formulation to Exubera™

Inhaled peptides and proteins have promise for respiratory and systemic disease treatment such as diabetes. This class of molecules is particularly well suited to formulation and processing by spray drying to achieve respirable engineered particles.

This webinar will discuss important aspects of formulation and process development for an inhaled biotherapeutic as well as describe important pre-clinical in vivo model methodologies required to understand biologic performance. Specifically, it will discuss pharmacokinetic and pharmacodynamic performance after pulmonary delivery of a DPI, providing an overview of a recent case study, demonstrating in vitro and in vivo inhalation performance of a novel spray-dried powder of insulin in comparison to Exubera™. 

Speakers:

• David Vodak, Ph.D., Senior Director, Pharmaceutical R&D, Capsugel
• Philip Kuehl, Ph.D., Research Scientist at Lovelace Respiratory Research Institute

Register here

Global Product Development in Capsule-based Dry Powder Inhaler for Emerging Markets

Product development in dry powder inhalation using capsules has grown exponentially around the world as formulators recognize the cost and flexibility advantages, especially for emerging markets. This webinar will overview challenges and opportunities in new product and generic development, identify specific devices and capsule customization based on drug requirements.

Who will benefit from attending?
Inhalation product developers, especially those focusing on generics and emerging markets applications.

Speakers:

• Matt Richardson, Ph.D., Manager, Pharmaceutical Business Development, Capsugel
• Burak Özsöğüt, Assistant General Manager, NEUTEC

Register here

Quality Risk Management for Excipients

As demand for high-quality excipients continues to grow, Capsugel will share its best practices and key learnings as a leading high-quality excipient manufacturer in a special session during the Excipients Innovations 2015 Online Event, Tuesday, March 31, 2015. The free annual event engages global participants about the future demands that will drive the drug excipients market in the future.

Kaat Bracquiné, Quality Control, Compliance & Regulatory Manager at Capsugel, will overview the regulatory background regarding the EU Directive on Falsified Medicines, the process and scope of the EXCiPACT™ excipient GMP certification and the related benefits to companies marketing pharmaceutical products in the EU. Bracquiné's session will be relevant for European manufacturers looking to secure independent validation that their sites maintain Good Manufacturing Practices (GMPs) and comply with current EU regulations.

See the webinar here: